Відмінності між версіями «Primarily based sexual well being interventions to stop STI/HIV in sub-Saharan Africa.»

Версія за 18:48, 8 лютого 2018

BMC Public Well being 2014 14:54.Submit your subsequent manuscript to BioMed Central and take complete benefit of:?Handy online submission ?Thorough peer overview ?No space constraints or colour figure charges ?Instant publication on acceptance ?Inclusion in PubMed, CAS, Scopus title= s40037-015-0222-8 and Google Scholar ?Analysis which can be freely available for redistributionSubmit your manuscript at www.biomedcentral.com/submit BMJ. 2004 Jan ten; 328(7431): 70.doi: 10.1136/bmj.328.7431.70-aPMCID: PMCHopes that Novartis deal on tuberculosis will spur donations for HIV and malariaFiona FleckCopyright ? 2004, BMJ title= peds.2015-0966 Publishing Group Ltd.A pledge last month by Swiss pharmaceuticals giant Novartis to donate 7m (��3.9m; �?.5m) worth of drugs to 500 000 individuals with tuberculosis in poor countries over the next five years has raised hopes that other drug organizations will stick to suit to fight HIV/AIDS and malaria.Under an agreement with the Globe Well being Organization on 19 December, Novartis will supply drugs to help poor nations Of bronchoalveolar cells and fluid utilizing lavage, which can then be acquire and distribute drugs to sufferers with tuberculosis. Two million persons die in the disease every single year, several of whom have HIV infection or AIDS. You will find indicators that the tuberculosis epidemic is developing.Aside from discounting of patented drugs (including antiretrovirals for HIV/AIDS) and a recent trade waiver to enable providers making generic drugs to manufacture copies of patented drugs, this can be the first time that a significant drug company has produced a sizable monetary donation.Rather than procuring vast quantities of drugs, which need sorting, Novartis is manufacturing prepared produced "patient kits" for the duration of patients' six month remedy course. The initial packs are as a consequence of be delivered this spring in quite a few countries��expected to involve the Philippines, Tanzania, Algeria, Syria, and Turkmenistan.The packs contain blister packs of 28 everyday doses. As opposed to taking 4 separate tablets a day, individuals take a single pill containing four unique drugs for two months and a single pill containing two drugs for 4 months.That is expected to help keep counterfeit drugs out of the chain and lessen the burden on healthcare workers, who will now only will need to provide sufferers access to their day-to-day dose and make a note that they've taken it. And it's going to be simpler for individuals to follow their therapy.The fixed combination drug method is central to WHO's purpose of delivering antiretroviral drugs to some 3 million patients with HIV/AIDS in poor nations by 2005, but so far it has been unclear how such big title= fnint.2013.00038 supplies of those drugs will be financed. In contrast to tuberculosis, the remedy will not quit just after six months, and, as it is probably to become challenging to get funding, any arrangement is probably to set a precedent.Novartis will manufacture the fixed combination antituberculosis drug in India. These will likely be administered beneath the DOTS (directly observed brief course) method of strict surveillance to prevent sufferers from stopping remedy, which can bring about a number of drug resistant tuberculosis strains."Novartis has come to be a significant force in the fight against tuberculosis," mentioned Dr Lee Jong-wook, WHO's director general. "We hope other people in the pharmaceutical indu.